Ganesh Padmanabhan, CEO and Co-founder, Autonomize AI
The U.S. healthcare system is drowning in paperwork. McKinsey estimates spending on healthcare administration to be over $950 billion annually. More importantly, the time required for administration takes…
Continue Reading
What You Should Know:
– While healthcare professionals widely recognize the transformative potential of generative AI (GenAI), most healthcare organizations are not yet adequately prepared to harness its full value, according to the new “2025…
Continue Reading
What You Should Know:
– ArcheHealth, a company poised to be a leader in healthcare operational intelligence has secured a $6.7M round of seed funding.
– The investment will fuel the launch of its AI-powered platform…
Continue Reading
Mass General Brigham researchers see value in a hybrid approach that makes use of generative artificial intelligence to diagnose patients. Comparing two arge language models – OpenAI’s GPT-4 and Google’s Gemini 1.5 – with its…
Continue Reading
The Critical Need for Medical Technology Advancement
Healthcare technology innovations continue revolutionizing patient care across hospitals and health systems nationwide. With medication errors contributing to nearly 7,000 deaths annually according to The Leapfrog Group, advanced…
The Royal Marsden NHS Foundation Trust is launching an AI radiology analysis service which runs on a clinical imaging platform to improve cancer research and patient outcomes.
The specialist cancer centre partnered with digital business…
Editor’s Note: This is the seventh in our series on Chief AI Officers in Healthcare. Other recent CAIO profiles include Dennis Chornenky at UC Davis Health, Dr. Karandeep Singh at UC San Diego Health,…
Continue Reading
What You Should Know:
– PathAI, a provider of AI-powered pathology solutions, and Northwestern Medicine, Chicago’s premier integrated academic health system announced a strategic multi-year collaboration aimed at transforming pathology diagnostics through the power of…
Continue Reading
This project represents the first systematic assessment of the US Food and Drug Administration’s postmarket surveillance of legally marketed artificial intelligence and machine learning based medical devices. We focus on the Manufacturer and User…
Continue Reading
What You Should Know:
– Vivodyne, a company pioneering an exclusively human-focused preclinical process, today announced it has raised $40M in new Series A funding led by Khosla Ventures, with participation from new investors Lingotto…
Continue Reading
